Article Name Global/International
Innovative software platform leverages artificial intelligence to personalize therapy decisions and improve clinical outcomes for prostate cancer patients.
10th July, 2025
New Therapeutic Breakthrough Offers Hope for Patients with Geographic Atrophy, the Advanced Form of Dry Age-Related Macular Degeneration
10th July, 2025
Study to Evaluate Renal Denervation Therapy’s Potential Benefits Beyond Hypertension Across Multiple Organ Systems
10th July, 2025
Strategic Acquisition Expands Companion Spine’s Portfolio in Motion-Preserving, Minimally Invasive Spine Therapies
09th July, 2025
Innovative Device Enhances Ease, Precision, and Accessibility for Patients Using Preservative-Free Eye Medications
09th July, 2025
Next-Generation Digital Stethoscope Recognized for Excellence in Design, Usability, and Clinical Impact
09th July, 2025
Revolutionary Implant Integrates Sensor-Driven Technology and Cloud Connectivity to Enhance Hearing Outcomes and Patient Monitoring
09th July, 2025
Breakthrough transcatheter aortic valve technology for aortic regurgitation and stenosis featured in front of global clinical audience during premier interventional cardiology event.
08th July, 2025
Pioneering next-generation sequencing technology delivers rapid, accurate pathogen identification to accelerate targeted treatment and improve patient outcomes across clinical settings.
08th July, 2025
Milestone enhances clinical use of the FARAPULSE™ Pulsed Field Ablation platform for treatment of atrial fibrillation, strengthening its role in next-generation cardiac electrophysiology.
08th July, 2025
Acquisition adds FDA-cleared Valeda® Light Delivery System to Alcon’s pipeline, targeting early and intermediate dry age-related macular degeneration through photobiomodulation technology
08th July, 2025
Regulatory milestone paves the way for expanded access to Morphic’s non-implant, incisionless solution for treating acid reflux and related gastrointestinal disorders across Europe.
08th July, 2025
Innovative thin-film formulation of cladribine moves forward as BioNxt prepares for next-stage development in multiple sclerosis therapy, aiming to enhance patient convenience and treatment adherence.
07th July, 2025
Enterprise Imaging Cloud Now Integrates Pathology for Streamlined Cancer Diagnostics and Cross-Disciplinary Collaboration
07th July, 2025
New microencapsulation technology ensures NADH stability and absorption, setting a new benchmark in cellular health and longevity supplements.
07th July, 2025
Ceramic-based hip resurfacing implant gains European regulatory approval, offering patients a bone-preserving, metal-free alternative for hip joint restoration.
04th July, 2025
FDA clears assay as companion diagnostic for ZEGFROVY™ and broad tumor profiling, advancing precision oncology diagnostics.
04th July, 2025
Dual AI-Powered Imaging Software Set to Enhance Diagnostic Confidence and Workflow Efficiency in MRI
03rd July, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer